Spinal Muscular Atrophy and Common Therapeutic Advances

Fetal Pediatr Pathol. 2019 Jun;38(3):226-238. doi: 10.1080/15513815.2018.1520374. Epub 2019 May 7.

Abstract

Background: Spinal muscular atrophy (SMA) is an autosomal recessive destructive motor neuron disease which is characterized primarily by the degeneration of α-motor neurons in the ventral gray horn of the spinal cord. It mainly affects children and represents the most common reason of inherited infant mortality.

Material and methods: We provide an overview of the recent therapeutic strategies for the treatment of SMA together with available and developing therapeutic strategies. For this purpose, Google Scholar and PubMed databases were searched for literature on SMA, therapy and treatment. Titles were reviewed and 96 were selected and assessed in this paper.

Result: Over the last two decades, different therapeutic strategies have been proposed for SMA. Some methods are in the pre-clinical, others the clinical phase.

Conclusion: By emergence of the new approaches, especially in gene therapy, effective treatment in the close future is probable.

Keywords: SMN1; SMN2; Spinal muscular atrophy; gene therapy; therapeutic approaches.

Publication types

  • Review

MeSH terms

  • Child
  • Genetic Therapy* / methods
  • Humans
  • Infant
  • Muscular Atrophy, Spinal / genetics*
  • Muscular Atrophy, Spinal / pathology
  • Muscular Atrophy, Spinal / therapy*
  • Nerve Tissue Proteins / genetics
  • Spinal Cord / pathology*
  • Survival of Motor Neuron 1 Protein / genetics
  • Survival of Motor Neuron 2 Protein / genetics

Substances

  • Nerve Tissue Proteins
  • SMN1 protein, human
  • SMN2 protein, human
  • Survival of Motor Neuron 1 Protein
  • Survival of Motor Neuron 2 Protein